The average revenue per occupied bed (ARPOB) is anticipated to grow moderately by 4-6 per cent in FY2025, following an 11 per cent rise in FY2024
Read More
India, often termed the diabetes capital of the world, faces a critical challenge with approximately 77 million adults suffering from Type 2 diabetes and an additional 25 million at high risk
Read More
The centre seeks to address the significant issue of high mortality from vaccine-preventable diseases among adults, a concern often overshadowed by childhood immunisation efforts
Read More
The collaboration aims to improve diabetes care through awareness campaigns, training for healthcare professionals, infrastructural support, and educational resources for lifestyle changes
Read More
Kriya becomes the first Indian company to secure MDSAP certification for five countries
Read More
This marks Quadria's second pharmaceutical exit via IPO in India within the past year
Read More
The Atellica CI analyser offers a comprehensive range of features, including the ability to test over 200 parameters across 20 disease states
Read More
The products are designed to enhance efficiency and safety in surgical environments, featuring advanced technology and user-friendly design.
Read More_20240806143940_original_image_8.webp)
The global smartwatch market is projected to surge from USD 33.58 billion in 2024 to USD 103.61 billion by 2032, reflecting the growing recognition of smartwatches for their substantial health benefits
Read More_20240805201922_original_image_25.webp)
There have been major regulatory shifts in medical devices for the use of safer substances, and PFAS (Per- and polyfluoroalkyl substances) plays a crucial role in the same
Read More
